rs200099217
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_006005.3(WFS1):c.2122C>T(p.Arg708Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000088 in 1,612,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R708R) has been classified as Likely benign.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.2122C>T | p.Arg708Cys | missense_variant | 8/8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.2122C>T | p.Arg708Cys | missense_variant | 8/8 | NP_001139325.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFS1 | ENST00000226760.5 | c.2122C>T | p.Arg708Cys | missense_variant | 8/8 | 1 | NM_006005.3 | ENSP00000226760 | P2 | |
ENST00000661896.1 | n.1337+1998G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152190Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000961 AC: 24AN: 249754Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135324
GnomAD4 exome AF: 0.0000815 AC: 119AN: 1460616Hom.: 0 Cov.: 98 AF XY: 0.0000798 AC XY: 58AN XY: 726620
GnomAD4 genome AF: 0.000151 AC: 23AN: 152190Hom.: 0 Cov.: 34 AF XY: 0.000148 AC XY: 11AN XY: 74340
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 708 of the WFS1 protein (p.Arg708Cys). This variant is present in population databases (rs200099217, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of autosomal recessive WFS1-related conditions (PMID: 11295831, 31264968; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 285046). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WFS1 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 23, 2020 | Reported previously in the heterozygous state in an individual with Wolfram syndrome who was also apparently homozygous for a WFS1 frameshift variant (Tessa et al., 2001).; Reported previously as a variant identified at a low frequency in individuals with type 1 diabetes (Awata et al., 2013); however, additional details were not provided to support the potential pathogenicity of this variant; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 31264968, 23856252, 15368487, 20972738, 11295831, 26435059, 18688868) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 02, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | Unlikely to be causative of autosomal dominant WFS1-related Wolfram syndrome and autosomal dominant WFS1-related low frequency sensorineural hearing loss Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Type 2 diabetes mellitus;C1833021:Autosomal dominant nonsyndromic hearing loss 6;C3280358:Wolfram-like syndrome;C3805412:Cataract 41;C4551693:Wolfram syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 04, 2022 | - - |
WFS1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 28, 2024 | The WFS1 c.2122C>T variant is predicted to result in the amino acid substitution p.Arg708Cys. This variant was reported in the heterozygous state in a patient with Wolfram syndrome, and was described as ‘probably neutral’ due the patient being homozygous for a different pathogenic premature termination variant (Tessa. 2001. PubMed ID: 11295831). This variant has also been described in a patient with type 1 diabetes (Table S6, Yu. 2019. PubMed ID: 31264968). This variant is reported in 0.020% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Dec 16, 2015 | ACMG Criteria: PP3 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at